In recent years, the pharma industry has seen significant growth in finding new uses for old drugs. The repurposing and repositioning of existing drugs have become an increasingly common way to find new treatments in recent years. Regulators are expecting some form of therapeutic rationale. Geraldine Venthoye, Executive Vice President Product Development, Vectura, looks at the opportunities for inhaled drugs.